14.01.2013 Views

Visit our Expo - Redox and Inflammation signaling 2012

Visit our Expo - Redox and Inflammation signaling 2012

Visit our Expo - Redox and Inflammation signaling 2012

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Session XVI : Chemopreventive agents Poster XVI, 10<br />

Resveratrol inhibits the growth of PA-1 ovarian cancer cells by down-regulating<br />

eEF1A2 expression<br />

Mee-Hyun Lee1, Bu-Young Choi2 <strong>and</strong> Young-Joon Surh1<br />

1National Research Laboratory of Molecular Carcinogenesis <strong>and</strong> Chemoprevention,<br />

College of Pharmacy, Seoul National University, Seoul 151-742 <strong>and</strong> 2C&C Research<br />

Labs, Hwasung City, Gyeonggi-do 445-970, South Korea<br />

The eukaryotic elongation factor 1A2 (eEF1A2), a subtype of eEF1A that is a key factor in<br />

the translational process of protein synthesis, promotes the transfer of animoacylated tRNAs<br />

to the A site of the ribosome. In human, eEF1A2 expression is restricted to the heart, brain,<br />

<strong>and</strong> skeletal muscle. Recently, eEF1A2 has been shown to be a potential oncogene that is<br />

over-expressed in ovarian cancer. Therefore, the regulation of inappropriate expression of<br />

eEF1A2 is considered as a rational strategy for ovarian cancer therapy. Resveratrol (3,4’,5trihydroxy<br />

stilbene), a phytoalexin present in grapes, has been reported to possess antioxidant,<br />

anti-inflammatory, <strong>and</strong> anti-carcinogenic activities. In the present study, we examined the<br />

anti-carcinogenic effect of resveratrol in PA-1 ovarian cancer cells considering eEF1A2 as a<br />

potential target. Resveratrol inhibited the growth of PA-1 cells. Treatment of PA-1 cells with<br />

insulin (10 µg/ml) or FBS (1%) resulted in the induction of eEF1A2. Pretreatment of PA-1<br />

cells with resveratrol suppressed insulin- or FBS-induced expression of eEF1A2. Previous<br />

studies have demonstrated that eEF1A2 confers anti-apoptotic effect by down-regulating<br />

caspase-3 activity. Resveratrol was found to induce caspase-3 activity <strong>and</strong> cause apoptosis in<br />

eEF1A2 over-expressing cells, suggesting that the induction of apoptosis by resveratrol in<br />

PA-1 cells is mediated, at least in part, via down-regulation of eEF1A2 expression. Taken<br />

together, these results suggest that oncogenic eEF1A2 is a potential target for ovarian cancer<br />

chemoprevention with resveratrol.<br />

- 602 -

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!